252 related articles for article (PubMed ID: 35752307)
1. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.
Evans N; Conley JM; Cardon M; Hartig P; Medlock-Kakaley E; Gray LE
Toxicol Appl Pharmacol; 2022 Aug; 449():116136. PubMed ID: 35752307
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in mouse, rat, and pooled human hepatocytes.
Heintz MM; Klaren WD; East AW; Haws LC; McGreal SR; Campbell RR; Thompson CM
Toxicol Sci; 2024 Jun; 200(1):165-182. PubMed ID: 38574381
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and PPARα knockout mouse hepatocytes.
Heintz MM; Klaren WD; East AW; Haws LC; McGreal SR; Campbell RR; Thompson CM
Toxicol Sci; 2024 Jun; 200(1):183-198. PubMed ID: 38574385
[TBL] [Abstract][Full Text] [Related]
4. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
[TBL] [Abstract][Full Text] [Related]
5. Estimation of Per- and Polyfluorinated Alkyl Substance Induction Equivalency Factors for Humpback Dolphins by Transactivation Potencies of Peroxisome Proliferator-Activated Receptors.
Sun X; Xie Y; Zhang X; Song J; Wu Y
Environ Sci Technol; 2023 Mar; 57(9):3713-3721. PubMed ID: 36812292
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the mode of action underlying development of liver lesions in mice following oral exposure to HFPO-DA and relevance to humans.
Heintz MM; Haws LC; Klaunig JE; Cullen JM; Thompson CM
Toxicol Sci; 2023 Mar; 192(1):15-29. PubMed ID: 36629480
[TBL] [Abstract][Full Text] [Related]
7. Adverse Maternal, Fetal, and Postnatal Effects of Hexafluoropropylene Oxide Dimer Acid (GenX) from Oral Gestational Exposure in Sprague-Dawley Rats.
Conley JM; Lambright CS; Evans N; Strynar MJ; McCord J; McIntyre BS; Travlos GS; Cardon MC; Medlock-Kakaley E; Hartig PC; Wilson VS; Gray LE
Environ Health Perspect; 2019 Mar; 127(3):37008. PubMed ID: 30920876
[TBL] [Abstract][Full Text] [Related]
8. Activation of human nuclear receptors by perfluoroalkylated substances (PFAS).
Behr AC; Plinsch C; Braeuning A; Buhrke T
Toxicol In Vitro; 2020 Feb; 62():104700. PubMed ID: 31676336
[TBL] [Abstract][Full Text] [Related]
9. A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health.
Rogers JM; Heintz MM; Thompson CM; Haws LC
Birth Defects Res; 2023 Jun; 115(11):1011-1062. PubMed ID: 37219003
[TBL] [Abstract][Full Text] [Related]
10. GenX analogs exposure induced greater hepatotoxicity than GenX mainly via activation of PPARα pathway while caused hepatomegaly in the absence of PPARα in female mice.
Ren W; Wang Z; Guo H; Gou Y; Dai J; Zhou X; Sheng N
Environ Pollut; 2024 Mar; 344():123314. PubMed ID: 38218542
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha.
Vanden Heuvel JP; Thompson JT; Frame SR; Gillies PJ
Toxicol Sci; 2006 Aug; 92(2):476-89. PubMed ID: 16731579
[TBL] [Abstract][Full Text] [Related]
12. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes.
Sadrabadi F; Alarcan J; Sprenger H; Braeuning A; Buhrke T
Arch Toxicol; 2024 Feb; 98(2):507-524. PubMed ID: 38117326
[TBL] [Abstract][Full Text] [Related]
13. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
[TBL] [Abstract][Full Text] [Related]
14. Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.
Nielsen G; Heiger-Bernays WJ; Schlezinger JJ; Webster TF
Toxicology; 2022 Jan; 465():153024. PubMed ID: 34743024
[TBL] [Abstract][Full Text] [Related]
15. Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS).
Conley JM; Lambright CS; Evans N; Medlock-Kakaley E; Hill D; McCord J; Strynar MJ; Wehmas LC; Hester S; MacMillan DK; Gray LE
Environ Int; 2022 Feb; 160():107056. PubMed ID: 34952357
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
Ojo AF; Peng C; Ng JC
Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
[TBL] [Abstract][Full Text] [Related]
18. Hexafluoropropylene oxide dimer acid (HFPO-DA) induced developmental cardiotoxicity and hepatotoxicity in hatchling chickens: Roles of peroxisome proliferator activated receptor alpha.
Xu X; Ni H; Guo Y; Lin Y; Ji J; Jin C; Yuan F; Feng M; Ji N; Zheng Y; Jiang Q
Environ Pollut; 2021 Dec; 290():118112. PubMed ID: 34500398
[TBL] [Abstract][Full Text] [Related]
19. Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat.
Conley JM; Lambright CS; Evans N; McCord J; Strynar MJ; Hill D; Medlock-Kakaley E; Wilson VS; Gray LE
Environ Int; 2021 Jan; 146():106204. PubMed ID: 33126064
[TBL] [Abstract][Full Text] [Related]
20. Baseline Toxicity Model to Identify the Specific and Nonspecific Effects of Per- and Polyfluoroalkyl Substances in Cell-Based Bioassays.
Qin W; Henneberger L; Glüge J; König M; Escher BI
Environ Sci Technol; 2024 Apr; 58(13):5727-5738. PubMed ID: 38394616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
